NSE · JENBURPH

Jenburkt Pharmaceuticals Limited

Sector: Healthcare · ISIN: INE354A01013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,030

of 5,084 stocks

▼ 241W

Peak #2,006 · 21 Sep 2026

Operating in Healthcare, Jenburkt Pharmaceuticals Limited trades at an undemanding earnings multiple, is growing revenue modestly, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap

407.79 Cr

P/E Ratio

11.74

P/B Ratio

2.07

ROE

17.63%

ROCE

25.11%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	35.51 Cr	44.63 Cr	43.02 Cr	45.56 Cr
Net Profit	5.89 Cr	10.85 Cr	5.93 Cr	10.16 Cr
EPS	13.34	24.58	13.44	23.03
Operating Profit	6.90 Cr	17.79 Cr	8.41 Cr	14.44 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

46.62%

Public

53.38%

PUBLIC BREAKDOWN

DII

0.12%

Individuals

44.15%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs